Concepedia

Amit Agarwal

AA

27

Publications

853

Citations

19

H-Index

2008

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Mount Sinai Hospital

Cedars-Sinai Medical Center

Indiana University – Purdue University Indianapolis

Wake Forest University

Amit Agarwal is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2008–2022

27

Publications

27

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

Sundar Jagannath, Yi Lin, Hartmut Goldschmidt et al. · Blood Cancer Journal · 2021 · 79 citations · Full text

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

David S. Siegel, Gary J. Schiller, Christy Samaras et al. · Leukemia · 2020 · 77 citations · Full text

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration

Kenneth C. Anderson, Daniel Auclair, Stacey J. Adam et al. · Clinical Cancer Research · 2021 · 62 citations · Full text

, , +18

Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment

Wenqing Qi, Catherine Spier, Xiaobing Liu et al. · Leukemia Research · 2012 · 53 citations · Full text

, , +9

Denosumab Chemotherapy for Recurrent Giant-Cell Tumor of Bone: A Case Report of Neoadjuvant Use Enabling Complete Surgical Resection

Amit Agarwal, Brandon T. Larsen, Lawrence Danso Buadu et al. · Case Reports in Oncological Medicine · 2013 · 52 citations · Full text

Rows per page

1–5 of 27